The Role of D-Dimer as a Diagnostic Biomarker of Thrombotic Events in Libyan Patients at EL-Beyda City

Stroke and thromboembolic events represent a global health issue of long-term disability and mortality. While neuroimaging is foundational for initial diagnosis, it has limitations in detecting subtle microvascular changes, making the integration of quantifiable blood-based biomarkers, such as D-dimer, critical for early diagnosis and prognostic evaluation. This study aims to evaluate the diagnostic utility of plasma D-dimer levels in patients with thrombosis by assessing its effectiveness as a clinical biomarker compared to healthy controls. This case-control study evaluated 120 participants aged ≥40 years, divided equally into 60 newly diagnosed thrombosis patients and 60 healthy controls at Al-Tarahum and Al-Thiqah Laboratories. Patients with chronic kidney disease, active malignancy, inflammatory disorders, or those on long-term anticoagulant therapy were excluded. Venous blood samples were collected in 3.2% sodium citrate, centrifuged, and stored at -80°C. Quantitative measurements of D-dimer were performed using the Fluorescence Immunoassay (FIA) technique via the ichroma™ system with a diagnostic cut-off value of 0.5µg/mL. Statistical analysis was conducted using SPSS version 26.0, applying independent-samples t-tests and Pearson correlation analysis. The cohort was well-balanced, consisting of 52.5% females and 47.5% males, with the majority of participants (63.3%) falling within the 40 to 60 years age group. A statistically significant positive correlation was identified between age and plasma D-dimer levels (r = 0.567, p = 0.001). Furthermore, thrombosis patients demonstrated a substantial and clinically significant elevation in mean D-dimer concentrations (1.500 ±0.32µg/mL) compared to the healthy control group (0.350 ± 0.12µg/mL, p < 0.001). Plasma D-dimer levels serve as a vital biomarker with high diagnostic and predictive value in thrombotic conditions, exhibiting a strong, statistically significant elevation in patients and a positive correlation with advancing age.

Authors

Publication Details

Journal
Attahadi Medical Journal
Published
2026-10-27
DOI
https://doi.org/10.69667/amj.26410
Primary Topic
Venous Thromboembolism Diagnosis and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Role of D-Dimer as a Diagnostic Biomarker of Thrombotic Events in Libyan Patients at EL-Beyda City

Tahani Mohammed
Attahadi Medical Journal
Venous Thromboembolism Diagnosis and Management
article

The Role of D-Dimer as a Diagnostic Biomarker of Thrombotic Events in Libyan Patients at EL-Beyda City

Tahani Mohammed
article en

Abstract

Stroke and thromboembolic events represent a global health issue of long-term disability and mortality. While neuroimaging is foundational for initial diagnosis, it has limitations in detecting subtle microvascular changes, making the integration of quantifiable blood-based biomarkers, such as D-dimer, critical for early diagnosis and prognostic evaluation. This study aims to evaluate the diagnostic utility of plasma D-dimer levels in patients with thrombosis by assessing its effectiveness as a clinical biomarker compared to healthy controls. This case-control study evaluated 120 participants aged ≥40 years, divided equally into 60 newly diagnosed thrombosis patients and 60 healthy controls at Al-Tarahum and Al-Thiqah Laboratories. Patients with chronic kidney disease, active malignancy, inflammatory disorders, or those on long-term anticoagulant therapy were excluded. Venous blood samples were collected in 3.2% sodium citrate, centrifuged, and stored at -80°C. Quantitative measurements of D-dimer were performed using the Fluorescence Immunoassay (FIA) technique via the ichroma™ system with a diagnostic cut-off value of 0.5µg/mL. Statistical analysis was conducted using SPSS version 26.0, applying independent-samples t-tests and Pearson correlation analysis. The cohort was well-balanced, consisting of 52.5% females and 47.5% males, with the majority of participants (63.3%) falling within the 40 to 60 years age group. A statistically significant positive correlation was identified between age and plasma D-dimer levels (r = 0.567, p = 0.001). Furthermore, thrombosis patients demonstrated a substantial and clinically significant elevation in mean D-dimer concentrations (1.500 ±0.32µg/mL) compared to the healthy control group (0.350 ± 0.12µg/mL, p < 0.001). Plasma D-dimer levels serve as a vital biomarker with high diagnostic and predictive value in thrombotic conditions, exhibiting a strong, statistically significant elevation in patients and a positive correlation with advancing age.

Attahadi Medical Journal
Good health and well-being
Openalex Percentile: Top 10%
Venous Thromboembolism Diagnosis and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
The Role of D-Dimer as a Diagnostic Biomarker of Thrombotic Events in Libyan Patients at EL-Beyda City — Tahani Mohammed · Attahadi Medical Journal (2026) | TGRS Research Map | TGRS